On-Demand Courses

Collaborative oncology: exploring the challenges and opportunities
Credits: 1.5 Category B
Open to: NDs Health-care practitioners Third-year students
Course type: On-demand

Course description
The Canadian College of Naturopathic Medicine (CCNM) and the Ontario Association of Naturopathic Doctors (OAND) hosted a panel discussions on collaborative care. The panel was titled collaborative oncology and consisted of a naturopathic doctor, two medical doctors, and a pharmacist who explored the challenges and opportunities of working collaboratively to enhance the care of patients suffering from cancer.
 
What is collaborative oncology?
What are the successes and challenges?
How can collaboration be improved?
Generously sponsored by Dr. Rogers Prize.

Instructor(s)/Speaker(s)
Daniel Lander
Daniel received a Bachelor of Science degree, with honours, in nutritional and nutraceutical sciences form the University of Guelph. He then went on to graduate from CCNM in 2006. During this time he developed a strong interest in the care of patients with cancer and went on to complete a two-year hospital-based residency at the Cancer Treatment Centers of America (CTCA) in Tulsa, Oklahoma. Daniel returned to CCNM as a full-time faculty member in 2011. He is currently an associate professor teaching naturopathic oncology and clinical nutrition, as well as supervising 4th year interns in the adjunctive cancer care shift at the RSNC.
Martina Trinkaus
Martina studied life sciences and physical health and education at Queen’s University prior to entering medical school in Toronto. Her internal medicine residency was completed at U of T along with her fellowship in hematology. Currently she is an assistant professor at U of T practising in malignant hematology at St. Michael's Hospital and currently functions as the adult hematology training program director with a focus on medical education.
Akbar Khan
Dr. Khan is a graduate of the University of Toronto, Faculty of Medicine (1992). After completion of his family medicine training in 1994, he joined a palliative home care team at his local hospital. This is how his focus on cancer patients began. In 2006, Dr. Khan co-founded Medicor Cancer Centres, the first integrated private cancer clinic of its kind in Canada. Since 2007, Dr. Khan gained international recognition for his work with the non-chemo drug dichloroacetate (DCA). He is privileged to be the first doctor in the world to prescribe off-label DCA to treat cancer with positive results. He is also the first in the world to demonstrate the curative potential of DCA when used as an adjuvant to chemotherapy or radiotherapy (one case published, others pending). Dr. Khan also uses low dose naltrexone (LDN) in his cancer practice.
Kathy Vu
Kathy is the clinical lead for safety initiatives and formulary pharmacist at Cancer Care Ontario. She is leading provincial initiatives including the updating of antiemetic recommendations, incident reporting in oncology and improving the safe dispensing of oral chemotherapy. Kathy graduated from the University of Toronto where she obtained her Bachelor of Science degree in pharmacy in 1999. She later went on to complete a hospital residency and her Doctor of Pharmacy degree. Prior to joining Cancer Care Ontario, Kathy was a clinical pharmacy practitioner at St. Michael's Hospital for 12 years. She practiced is in the area of hematology and oncology where she provided pharmaceutical care to cancer patients with complex medication needs.